| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1464-410X.2004.04858.X |
| P698 | PubMed publication ID | 15180635 |
| P2093 | author name string | Dixon AK | |
| Turner WH | |||
| Ferguson DR | |||
| Elneil S | |||
| Tempest HV | |||
| Sellers LA | |||
| P433 | issue | 9 | |
| P304 | page(s) | 1344-1348 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | BJU International | Q4835773 |
| P1476 | title | P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis | |
| P478 | volume | 93 |
| Q34298261 | A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study |
| Q37743301 | A review of botulinum toxin use for chronic pelvic pain syndrome |
| Q33919968 | ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells |
| Q36057867 | Afferent nerve regulation of bladder function in health and disease |
| Q39848697 | Altered expression of P2X3 in vagal and spinal afferents following esophagitis in rats |
| Q39644065 | Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria. |
| Q56983718 | An ex vivo bladder model with detrusor smooth muscle removed to analyze biologically active mediators released from the suburothelium |
| Q34158044 | Bladder sensory physiology: neuroactive compounds and receptors, sensory transducers, and target-derived growth factors as targets to improve function |
| Q89683175 | Can Botulinum Toxin A Play A Role In Treatment Of Chronic Pelvic Pain Syndrome In Female Patients?-Clinical and Animal Evidence |
| Q33570078 | Cell biology and physiology of the uroepithelium |
| Q37421999 | Changes in adenosine triphosphate-stimulated ATP release suggest association between cytokine and purinergic signaling in bladder urothelial cells |
| Q33302963 | Changes in muscarinic receptors in the toad urothelial cell line TBM-54 following acrolein treatment |
| Q33608790 | Correlation between urothelial differentiation and sensory proteins P2X3, P2X5, TRPV1, and TRPV4 in normal urothelium and papillary carcinoma of human bladder |
| Q37137251 | Cyclophosphamide-induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons |
| Q35543206 | Defining protein expression in the urothelium: a problem of more than transitional interest |
| Q39860148 | Differential ectonucleotidase expression in human bladder cancer cell lines |
| Q33817780 | Differential purinergic signaling in bladder sensory neurons of naïve and bladder-inflamed mice |
| Q36628753 | Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis |
| Q40215681 | Effects of Saw Palmetto Extract on Urodynamic Parameters, Bladder Muscarinic and Purinergic Receptors and Urinary Cytokines in Rats with Cyclophosphamide-Induced Cystitis |
| Q30234888 | Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome |
| Q26824708 | Evidence for bladder urothelial pathophysiology in functional bladder disorders |
| Q33886615 | Expression and distribution of ectonucleotidases in mouse urinary bladder |
| Q37383394 | Expression and function of rat urothelial P2Y receptors |
| Q40016409 | Expression of purinergic P2X2-receptors in neurogenic bladder dysfunction due to spinal cord injury: a preliminary immunohistochemical study |
| Q36788773 | Extracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway |
| Q37093652 | Functional expression of purinergic P2 receptors and transient receptor potential channels by the human urothelium |
| Q27010351 | How does the urothelium affect bladder function in health and disease? ICI-RS 2011 |
| Q42469009 | Inhibition of urothelial P2X3 receptors prevents desensitization of purinergic detrusor contractions in the rat bladder. |
| Q37330911 | Introduction and perspective, historical note |
| Q39263860 | Is electrolyte transfer across the urothelium important?: ICI-RS 2015. |
| Q35740154 | Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder. |
| Q42933872 | Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis |
| Q36445282 | Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction |
| Q33556343 | MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome |
| Q24617046 | Molecular and functional properties of P2X receptors--recent progress and persisting challenges |
| Q36225080 | More than just a barrier: urothelium as a drug target for urinary bladder pain |
| Q46445213 | Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics |
| Q26828785 | Neural control of the lower urinary tract |
| Q34579044 | Neural upregulation in interstitial cystitis |
| Q35418701 | New aspects in the differential diagnosis and therapy of bladder pain syndrome/interstitial cystitis |
| Q36395040 | New theories in interstitial cystitis |
| Q28087509 | Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection |
| Q48460330 | P2X receptor ligands and pain |
| Q37135470 | P2X receptor-mediated purinergic sensory pathways to the spinal cord dorsal horn |
| Q34191750 | P2X2 and P2X3 receptor expression in postnatal and adult rat urinary bladder and lumbosacral spinal cord |
| Q36977790 | P2X3 receptor involvement in pain states |
| Q48091404 | Pirt reduces bladder overactivity by inhibiting purinergic receptor P2X3. |
| Q98292017 | Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation |
| Q37148393 | Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts |
| Q38061933 | Purinergic signalling in the lower urinary tract |
| Q37620260 | Purinergic signalling in the urinary tract in health and disease |
| Q54205799 | Purinergic signalling underlies transforming growth factor-β-mediated bladder afferent nerve hyperexcitability. |
| Q37586481 | Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation |
| Q34516186 | Receptors, channels, and signalling in the urothelial sensory system in the bladder |
| Q26801459 | Research Findings on Overactive Bladder |
| Q33153354 | Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes |
| Q34973917 | Role of Purinergic Signaling in Voiding Dysfunction |
| Q52340820 | Role of neurogenic inflammation in local communication in the visceral mucosa. |
| Q36274120 | Role of the urothelium in urinary bladder dysfunction following spinal cord injury |
| Q28483883 | Sensory dysfunction of bladder mucosa and bladder oversensitivity in a rat model of metabolic syndrome |
| Q34080499 | Signalling molecules in the urothelium |
| Q49532787 | TRPV1 enhances the afferent response to P2X receptor activation in the mouse urinary bladder |
| Q90457679 | The Urothelium: Life in a Liquid Environment |
| Q42711315 | The function of P2X3 receptor and NK1 receptor antagonists on cyclophosphamide-induced cystitis in rats |
| Q35657943 | The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice. |
| Q36898688 | The uroepithelial-associated sensory web. |
| Q37103157 | The use of botulinum neurotoxin type A (BoNTA) in urology |
| Q37011767 | Therapeutic receptor targets for lower urinary tract dysfunction |
| Q38174276 | Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences? |
| Q36557510 | Urinary bladder urothelium: molecular sensors of chemical/thermal/mechanical stimuli |
| Q30412893 | Urinary bladder, cystitis and nerve/urothelial interactions |
| Q41630770 | Urothelial purine release during filling of murine and primate bladders |
| Q38996469 | Urothelium update: how the bladder mucosa measures bladder filling |
| Q35164413 | Visceral pain: the neurophysiological mechanism |
Search more.